SIRT1 has been reported to attenuate neuropathic pain in diabetes through suppression of mGluR1/5 by facilitating H3 acetylation at the promoter region of mGluR1/5-encoding Grm1/5 [271]. Here, SIRT1 is linked to diabetes mellitus.